Good Health
Answers to your questions about sex, hair, mental health,
weight loss, and more—from Clyne Health.
FDA Approves Orforglipron: What It Means for Weight Loss
Orforglipron is the first non-peptide, oral GLP-1 receptor agonist approved for weight loss. Here is what makes it different and what it means for the future of obesity treatment.
The Rise of Compounded GLP-1 Medications
Compounded GLP-1 medications have filled a critical access gap during supply shortages. Here is how compounding works, what the regulatory landscape looks like, and what members should know.
Telehealth and Obesity Care: Where the Industry Is Heading
Telehealth has fundamentally changed how obesity is treated. Here is where the industry stands today and what the next wave of innovation looks like.
Latest
FDA Approves Orforglipron: What It Means for Weight Loss
Orforglipron is the first non-peptide, oral GLP-1 receptor agonist approved for weight loss. Here is what makes it different and what it means for the future of obesity treatment.
The Rise of Compounded GLP-1 Medications
Compounded GLP-1 medications have filled a critical access gap during supply shortages. Here is how compounding works, what the regulatory landscape looks like, and what members should know.
Telehealth and Obesity Care: Where the Industry Is Heading
Telehealth has fundamentally changed how obesity is treated. Here is where the industry stands today and what the next wave of innovation looks like.
Why Clyne Is Building the Health Concierge of the Future
From AI-assisted treatment to connected device insights — here's the vision behind the Clyne platform.
Get Help Anytime
Chat with a doctor when you need support or a refill, 100% online from your phone.